1
|
Yamaguchi J, Matoba T, Kikuchi M, Minami Y, Kojima S, Hanada H, Mano T, Nakashima T, Hashiba K, Yamamoto T, Tanaka A, Matsuo K, Nakayama N, Nomura O, Tahara Y, Nonogi H. Effects of Door-In to Door-Out Time on Mortality Among ST-Segment Elevation Myocardial Infarction Patients Transferred for Primary Percutaneous Coronary Intervention ― Systematic Review and Meta-Analysis ―. Circ Rep 2022; 4:109-115. [PMID: 35342837 PMCID: PMC8901244 DOI: 10.1253/circrep.cr-21-0160] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/06/2022] [Revised: 01/31/2022] [Accepted: 02/08/2022] [Indexed: 12/24/2022] Open
Abstract
Background:
Primary percutaneous coronary intervention (PCI) for ST-elevation myocardial infarction (STEMI) is now widely accepted. Recent guidelines have focused on total ischemic time, because shorter total ischemic time is associated with a more favorable prognosis. The door-in to door-out (DIDO) time, defined as time from arrival at a non-PCI-capable hospital to leaving for a PCI-capable hospital, may affect STEMI patient prognosis. However, a relevant meta-analysis is lacking. Methods and Results:
We searched PubMed for clinical studies comparing short-term (30-day and in-hospital) mortality rates of STEMI patients undergoing primary PCI with DIDO times of ≤30 vs. >30 min. Two investigators independently screened the search results and extracted the data. Random effects estimators with weights calculated by the inverse variance method were used to determine pooled risk ratios. The search retrieved 1,260 studies; of these, 2 retrospective cohort studies (15,596 patients) were analyzed. In the DIDO time ≤30 and >30 min groups, the primary endpoint (i.e., in-hospital or 30-day mortality) occurred for 51 of 1,794 (2.8%) and 831 of 13,802 (6.0%) patients, respectively. The incidence of the primary endpoint was significantly lower in the DIDO time ≤30 min group (odds ratio 0.45; 95% confidence interval 0.34–0.60). Conclusions:
Our findings suggest that a DIDO time ≤30 min is associated with a lower short-term mortality rate. However, further larger systematic reviews and meta-analyses are needed to validate our findings.
Collapse
Affiliation(s)
| | - Tetsuya Matoba
- Department of Cardiovascular Medicine, Kyushu University Faculty of Medical Sciences
| | - Migaku Kikuchi
- Department of Cardiovascular Medicine, Emergency and Critical Care Center, Dokkyo Medical University
| | | | - Sunao Kojima
- Department of Internal Medicine, Sakurajyuji Yatsushiro Rehabilitation Hospital
| | - Hiroyuki Hanada
- Department of Emergency and Disaster Medicine, Hirosaki University
| | | | - Takahiro Nakashima
- Department of Emergency Medicine and Michigan Center for Integrative Research in Critical Care, University of Michigan
| | | | - Takeshi Yamamoto
- Division of Cardiovascular Intensive Care, Nippon Medical School Hospital
| | - Akihito Tanaka
- Department of Cardiology, Nagoya University Graduate School of Medicine
| | - Kunihiro Matsuo
- Department of Acute Care Medicine, Fukuoka University Chikushi Hospital
| | - Naoki Nakayama
- Department of Cardiology, Kanagawa Cardiovascular and Respiratory Center
| | - Osamu Nomura
- Department of Emergency and Disaster Medicine, Hirosaki University
| | - Yoshio Tahara
- Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center
| | | | | |
Collapse
|
2
|
Nguyen DD, Doll JA. Quality Improvement and Public Reporting in STEMI Care. Interv Cardiol Clin 2021; 10:391-400. [PMID: 34053625 DOI: 10.1016/j.iccl.2021.03.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Mortality rates for patients with ST-segment elevation myocardial infarction (STEMI) remain high despite development of novel drugs and interventions over the past several decades. There is significant variability between hospitals in use of evidence-based treatments, and substantial opportunities exist to optimize care pathways and reduce disparities in care delivery. Quality improvement interventions implemented at local, regional, and national levels have improved care processes and patient outcomes. This article reviews evidence for quality improvement interventions along the spectrum of STEMI care, describes existing systems for quality measurement, and examines local and national policy interventions, with special attention to public reporting programs.
Collapse
Affiliation(s)
- Dan D Nguyen
- Division of Cardiology, Department of Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA
| | - Jacob A Doll
- Division of Cardiology, Department of Medicine, University of Washington, 1959 NE Pacific Street, Seattle, WA 98195, USA; VA Puget Sound Health Care System, 1660 S Columbian Way, Seattle, WA 98108, USA.
| |
Collapse
|
3
|
McTaggart RA, Moldovan K, Oliver LA, Dibiasio EL, Baird GL, Hemendinger ML, Haas RA, Goyal M, Wang TY, Jayaraman MV. Door-in-Door-Out Time at Primary Stroke Centers May Predict Outcome for Emergent Large Vessel Occlusion Patients. Stroke 2018; 49:2969-2974. [PMID: 30571428 DOI: 10.1161/strokeaha.118.021936] [Citation(s) in RCA: 55] [Impact Index Per Article: 9.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Background and Purpose—
Interfacility transfers for thrombectomy in stroke patients with emergent large vessel occlusion (ELVO) are associated with longer treatment times and worse outcomes. In this series, we examined the association between Primary Stroke Center (PSC) door-in to door-out (DIDO) times and outcomes for confirmed ELVO stroke transfers and factors that may modify the interaction.
Methods—
We retrospectively identified 160 patients transferred to a single Comprehensive Stroke Center (CSC) with anterior circulation ELVO between July 1, 2015 and May 30, 2017. We included patients with acute occlusions of the internal carotid artery or proximal middle cerebral artery (M1 or M2 segments), with a National Institutes of Health Stroke Scale score of ≥6. Workflow metrics included time from onset to recanalization, PSC DIDO, interfacility transfer time, CSC arrival to arterial puncture, and arterial puncture to recanalization. Primary outcome measure was National Institutes of Health Stroke Scale at discharge and modified Rankin Scale (mRS) score at 90 days.
Results—
The median (Q1–Q3) age and National Institutes of Health Stroke Scale of the 130 ELVO transfers analyzed was 75 (64–84) and 17 (11–22). Intravenous alteplase was administered to 64% of patients. Regarding specific workflow metrics, median (Q1–Q3) times (in minutes) were 241 (199–332) for onset to recanalization, 85 (68–111) for PSC DIDO, 26 (17–32) for interfacility transport, 21 (16–39) for CSC door to arterial puncture, and 24 (15–35) for puncture to recanalization. Median discharge National Institutes of Health Stroke Scale score was 5 (2–16), and 46 (35%) patients had a favorable outcome at 90 days. Complete reperfusion (modified Thrombolysis in Cerebral Ischemia 2c/3) modified the deleterious association of DIDO on outcome.
Conclusions—
For patients diagnosed with ELVO at a PSC who are being transferred to a CSC for thrombectomy, longer DIDO times may have a deleterious effect on outcomes and may represent the single biggest modifiable factor in onset to recanalization time. PSCs should make efforts to decrease DIDO and routine use of DIDO as a performance measure is encouraged.
Collapse
Affiliation(s)
- Ryan A. McTaggart
- From the Department of Diagnostic Imaging (R.A.M., E.L.D., G.L.B., R.A.H., M.V.J.), Rhode Island Hospital, Providence
- Department of Neurology (R.A.M., L.A.O., R.A.H., M.L.H., M.V.J.), Rhode Island Hospital, Providence
- Department of Neurosurgery (R.A.M., K.M., R.A.H., M.V.J.), Rhode Island Hospital, Providence
- Warren Alpert School of Medicine at Brown University, The Norman Prince Neuroscience Institute (R.A.M., L.A.O., R.A.H., M.V.J.), Rhode Island Hospital, Providence
| | - Krisztina Moldovan
- Department of Neurosurgery (R.A.M., K.M., R.A.H., M.V.J.), Rhode Island Hospital, Providence
| | - Lori A. Oliver
- Department of Neurology (R.A.M., L.A.O., R.A.H., M.L.H., M.V.J.), Rhode Island Hospital, Providence
- Warren Alpert School of Medicine at Brown University, The Norman Prince Neuroscience Institute (R.A.M., L.A.O., R.A.H., M.V.J.), Rhode Island Hospital, Providence
| | - Eleanor L. Dibiasio
- From the Department of Diagnostic Imaging (R.A.M., E.L.D., G.L.B., R.A.H., M.V.J.), Rhode Island Hospital, Providence
| | - Grayson L. Baird
- From the Department of Diagnostic Imaging (R.A.M., E.L.D., G.L.B., R.A.H., M.V.J.), Rhode Island Hospital, Providence
- Lifespan Biostatistics Core (G.L.B.), Rhode Island Hospital, Providence
| | | | - Richard A. Haas
- From the Department of Diagnostic Imaging (R.A.M., E.L.D., G.L.B., R.A.H., M.V.J.), Rhode Island Hospital, Providence
- Department of Neurology (R.A.M., L.A.O., R.A.H., M.L.H., M.V.J.), Rhode Island Hospital, Providence
- Department of Neurosurgery (R.A.M., K.M., R.A.H., M.V.J.), Rhode Island Hospital, Providence
- Warren Alpert School of Medicine at Brown University, The Norman Prince Neuroscience Institute (R.A.M., L.A.O., R.A.H., M.V.J.), Rhode Island Hospital, Providence
| | - Mayank Goyal
- Department of Radiology, Seaman Family MR Research Centre, Foothills Medical Center, Calgary, Canada (M.G.)
| | - Tracy Y. Wang
- Duke Clinical Research Institute, Duke University Medical Center, Durham, NC (T.Y.W.)
| | - Mahesh V. Jayaraman
- From the Department of Diagnostic Imaging (R.A.M., E.L.D., G.L.B., R.A.H., M.V.J.), Rhode Island Hospital, Providence
- Department of Neurology (R.A.M., L.A.O., R.A.H., M.L.H., M.V.J.), Rhode Island Hospital, Providence
- Department of Neurosurgery (R.A.M., K.M., R.A.H., M.V.J.), Rhode Island Hospital, Providence
- Warren Alpert School of Medicine at Brown University, The Norman Prince Neuroscience Institute (R.A.M., L.A.O., R.A.H., M.V.J.), Rhode Island Hospital, Providence
| |
Collapse
|